OCX
OncoCyte Corp
Halal Rating :
Last Price
$2.09
Last updated:
Market Cap
-
7D Change
0.48%
1 Year Change
-36.67%
Company Overview
Industries
Exchange
Next Earnings Date
OncoCyte Corporation is a molecular diagnostics company focused on developing and commercializing diagnostic tests for early detection and risk stratification of cancer. The company's platform technology aims to provide non-invasive and cost-effective alternatives to traditional diagnostic procedures. Their main focus is on developing tests for lung cancer, breast cancer, and other types of cancer.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $115000.0 | $13.66m | - | $31000.0 | 0.00% | 0.23% |
| June 30, 2024 | $104000.0 | $4.74m | - | $8000.0 | 0.00% | 0.17% |
| March 31, 2024 | $176000.0 | $9.44m | - | $15000.0 | 0.00% | 0.16% |
Company Impact
Help us evaluate OncoCyte Corp's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.